AGN 3.33% 77.5¢ argenica therapeutics limited

The review of the safety data after the first 23 patients is...

  1. 107 Posts.
    lightbulb Created with Sketch. 28
    The review of the safety data after the first 23 patients is due. The CEO said on a recent webinar that this would occur in early September as the neurologists involved had scheduling difficulties getting together causing a delay. I would anticipate that by now many more than 23 patients have been recruited with all 10 sites now open. I am surprised this has not yet been released. Hopefully, it is imminent
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
(20min delay)
Last
77.5¢
Change
0.025(3.33%)
Mkt cap ! $99.27M
Open High Low Value Volume
76.0¢ 77.5¢ 75.0¢ $154.6K 203.2K

Buyers (Bids)

No. Vol. Price($)
2 7819 76.0¢
 

Sellers (Offers)

Price($) Vol. No.
77.5¢ 5457 1
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.